As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Dementia affected an estimated 55.2million ... While that world does not currently exist, Dr Gourlay said the new drug is close to proving it can deliver just that. While a drug for Alzheimer's ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

The findings show that the increased ... Study Identifies Potential New Drug for Parkinson's-Related Cognitive Decline, Dementia Nov. 19, 2024 — A recently published study found that a tiny ...

D imaging and organoid models are revolutionizing dementia research, offering deeper insights into disease mechanisms and ...

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...

Alpha Cognition and China Medical System sign a $44M licensing deal for Zunveyl. ALPHA-1062 preclinical data shows benefits ...

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...

How Dementia Affects the ... of Huntington's disease (HD), according to a new ... 'Alzheimer's in Dish' Model Shows Promise for Accelerating Drug Discovery Nov. 27, 2024 — A decade ago ...

There is a potential link between Alzheimer's disease and the herpes simplex virus-1 (HSV-1), which is a common cause for ...

A new study reveals that common cardiovascular conditions like high blood pressure and diabetes, known to damage brain blood ...

Getting a good night's sleep is a critical part of our daily biological cycle and is associated with improved brain function, ...